Loading…
Effect of enrofloxacin on Haemophilus parasuis infection, disease and immune response
•Enrofloxacin treatment before low dose H. parasuis inoculation did not interfere with H. parasuis infection, subsequent seroconversion, and protection against challenge.•Pigs treated with enrofloxacin after low dose H. parasuis inoculation did not seroconvert and were susceptible to subsequent chal...
Saved in:
Published in: | Veterinary microbiology 2017-02, Vol.199, p.91-99 |
---|---|
Main Authors: | , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | cdi_FETCH-LOGICAL-c502t-73133429fc90ae0ad24289d5c5f74946f3c8885f507eae4271f08ecb8fee496a3 |
---|---|
cites | cdi_FETCH-LOGICAL-c502t-73133429fc90ae0ad24289d5c5f74946f3c8885f507eae4271f08ecb8fee496a3 |
container_end_page | 99 |
container_issue | |
container_start_page | 91 |
container_title | Veterinary microbiology |
container_volume | 199 |
creator | Macedo, Nubia Cheeran, Maxim C.J. Rovira, Albert Holtcamp, Andrew Torremorell, Montserrat |
description | •Enrofloxacin treatment before low dose H. parasuis inoculation did not interfere with H. parasuis infection, subsequent seroconversion, and protection against challenge.•Pigs treated with enrofloxacin after low dose H. parasuis inoculation did not seroconvert and were susceptible to subsequent challenge.•Results from this study can help determine timing of antimicrobial use and contribute to our current understanding of judicious antibiotic use.
Haemophilus parasuis, the causative agent of Glasser’s disease, is a pathogen that colonizes the upper respiratory tract (URT) of pigs, invades the bloodstream and causes polyserositis. Because antimicrobials are highly effective against H. parasuis, we hypothesized that they could have a detrimental effect on the establishment of an immune response if given at the time of URT colonization. In this study, we characterized clinical outcomes and antibody and IFN-γ responses to H. parasuis in pigs treated with enrofloxacin before or after low dose inoculation with a pathogenic H. parasuis strain. Pigs that were only inoculated with the agent (EXP group) and pigs that were treated with enrofloxacin and then inoculated (ABT/EXP group) developed signs of disease starting at 4days post inoculation (DPI), presented a significant increase in serum IgG and were protected against a subsequent homologous challenge. In contrast, pigs treated with antibiotic after inoculation (EXP/ABT group) neither showed signs of disease nor seroconverted (IgG) after low dose inoculation. EXP/ABT pigs as well as naïve control pigs [enrofloxacin only (ABT) and challenge only (CHA)] were susceptible to challenge. Variable levels of antibodies in bronchioalveolar fluid and IFN-γ in peripheral blood mononuclear cells were observed after H. parasuis inoculation, but were not associated with protection. In summary, only pigs treated before low dose H. parasuis inoculation seroconverted and were protected against subsequent challenge. Results from this study can help determine timing of antimicrobial use and contribute to our current understanding of judicious antibiotic use. |
doi_str_mv | 10.1016/j.vetmic.2016.12.032 |
format | article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1861594416</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0378113516302942</els_id><sourcerecordid>1963135618</sourcerecordid><originalsourceid>FETCH-LOGICAL-c502t-73133429fc90ae0ad24289d5c5f74946f3c8885f507eae4271f08ecb8fee496a3</originalsourceid><addsrcrecordid>eNp9kE1r3DAQhkVJaTZp_0Epglx6qF2NPmz5UghhmwQCvTRnocgjqsWWXGkdkn9fLZv20ENOw8DzzsdDyEdgLTDovu7aR9zPwbW8di3wlgn-hmxA96LhSvITsmGi1w2AUKfkrJQdY0wOHXtHTrkGYP3AN-R-6z26PU2eYszJT-nJuhBpivTG4pyWX2FaC11stmUNhYZ4wEOKX-gYCtqC1MaRhnleI9KMZUmx4Hvy1tup4IeXek7uv29_Xt00dz-ub68u7xqnGN83vQAhJB-8G5hFZkcuuR5G5ZTv5SA7L5zWWnnFerQoeQ-eaXQP2iPWT6w4J5-Pc5ecfq9Y9mYOxeE02YhpLQZ0B2qQErqKXvyH7tKaY73OwNDVQ1QHulLySLmcSsnozZLDbPOzAWYO2s3OHLWbg3YD3FTtNfbpZfj6MOP4L_TXcwW-HQGsNh4DZlNcwOhwDLn6NGMKr2_4A63LlQg</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1963135618</pqid></control><display><type>article</type><title>Effect of enrofloxacin on Haemophilus parasuis infection, disease and immune response</title><source>ScienceDirect Journals</source><creator>Macedo, Nubia ; Cheeran, Maxim C.J. ; Rovira, Albert ; Holtcamp, Andrew ; Torremorell, Montserrat</creator><creatorcontrib>Macedo, Nubia ; Cheeran, Maxim C.J. ; Rovira, Albert ; Holtcamp, Andrew ; Torremorell, Montserrat</creatorcontrib><description>•Enrofloxacin treatment before low dose H. parasuis inoculation did not interfere with H. parasuis infection, subsequent seroconversion, and protection against challenge.•Pigs treated with enrofloxacin after low dose H. parasuis inoculation did not seroconvert and were susceptible to subsequent challenge.•Results from this study can help determine timing of antimicrobial use and contribute to our current understanding of judicious antibiotic use.
Haemophilus parasuis, the causative agent of Glasser’s disease, is a pathogen that colonizes the upper respiratory tract (URT) of pigs, invades the bloodstream and causes polyserositis. Because antimicrobials are highly effective against H. parasuis, we hypothesized that they could have a detrimental effect on the establishment of an immune response if given at the time of URT colonization. In this study, we characterized clinical outcomes and antibody and IFN-γ responses to H. parasuis in pigs treated with enrofloxacin before or after low dose inoculation with a pathogenic H. parasuis strain. Pigs that were only inoculated with the agent (EXP group) and pigs that were treated with enrofloxacin and then inoculated (ABT/EXP group) developed signs of disease starting at 4days post inoculation (DPI), presented a significant increase in serum IgG and were protected against a subsequent homologous challenge. In contrast, pigs treated with antibiotic after inoculation (EXP/ABT group) neither showed signs of disease nor seroconverted (IgG) after low dose inoculation. EXP/ABT pigs as well as naïve control pigs [enrofloxacin only (ABT) and challenge only (CHA)] were susceptible to challenge. Variable levels of antibodies in bronchioalveolar fluid and IFN-γ in peripheral blood mononuclear cells were observed after H. parasuis inoculation, but were not associated with protection. In summary, only pigs treated before low dose H. parasuis inoculation seroconverted and were protected against subsequent challenge. Results from this study can help determine timing of antimicrobial use and contribute to our current understanding of judicious antibiotic use.</description><identifier>ISSN: 0378-1135</identifier><identifier>EISSN: 1873-2542</identifier><identifier>DOI: 10.1016/j.vetmic.2016.12.032</identifier><identifier>PMID: 28110792</identifier><language>eng</language><publisher>Netherlands: Elsevier B.V</publisher><subject>Animals ; Anti-Bacterial Agents - administration & dosage ; Antibiotics ; Antibodies, Bacterial - blood ; Antimicrobial agents ; Bacterial infections ; Colonization ; Enrofloxacin ; Female ; Fluoroquinolones - administration & dosage ; Glasser's disease ; Group dynamics ; Haemophilus ; Haemophilus Infections - drug therapy ; Haemophilus Infections - immunology ; Haemophilus Infections - veterinary ; Haemophilus parasuis ; Haemophilus parasuis - immunology ; Homology ; Immune response ; Immunity ; Immunity (Disease) ; Immunoglobulin G ; Inoculation ; Interferon ; Interferon-gamma - blood ; Leukocytes (mononuclear) ; Male ; Peripheral blood mononuclear cells ; Polyserositis ; Random Allocation ; Respiratory tract ; Swine ; Swine Diseases - drug therapy ; Swine Diseases - immunology ; Time Factors</subject><ispartof>Veterinary microbiology, 2017-02, Vol.199, p.91-99</ispartof><rights>2016 Elsevier B.V.</rights><rights>Copyright © 2016 Elsevier B.V. All rights reserved.</rights><rights>Copyright Elsevier BV Feb 2017</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c502t-73133429fc90ae0ad24289d5c5f74946f3c8885f507eae4271f08ecb8fee496a3</citedby><cites>FETCH-LOGICAL-c502t-73133429fc90ae0ad24289d5c5f74946f3c8885f507eae4271f08ecb8fee496a3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/28110792$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Macedo, Nubia</creatorcontrib><creatorcontrib>Cheeran, Maxim C.J.</creatorcontrib><creatorcontrib>Rovira, Albert</creatorcontrib><creatorcontrib>Holtcamp, Andrew</creatorcontrib><creatorcontrib>Torremorell, Montserrat</creatorcontrib><title>Effect of enrofloxacin on Haemophilus parasuis infection, disease and immune response</title><title>Veterinary microbiology</title><addtitle>Vet Microbiol</addtitle><description>•Enrofloxacin treatment before low dose H. parasuis inoculation did not interfere with H. parasuis infection, subsequent seroconversion, and protection against challenge.•Pigs treated with enrofloxacin after low dose H. parasuis inoculation did not seroconvert and were susceptible to subsequent challenge.•Results from this study can help determine timing of antimicrobial use and contribute to our current understanding of judicious antibiotic use.
Haemophilus parasuis, the causative agent of Glasser’s disease, is a pathogen that colonizes the upper respiratory tract (URT) of pigs, invades the bloodstream and causes polyserositis. Because antimicrobials are highly effective against H. parasuis, we hypothesized that they could have a detrimental effect on the establishment of an immune response if given at the time of URT colonization. In this study, we characterized clinical outcomes and antibody and IFN-γ responses to H. parasuis in pigs treated with enrofloxacin before or after low dose inoculation with a pathogenic H. parasuis strain. Pigs that were only inoculated with the agent (EXP group) and pigs that were treated with enrofloxacin and then inoculated (ABT/EXP group) developed signs of disease starting at 4days post inoculation (DPI), presented a significant increase in serum IgG and were protected against a subsequent homologous challenge. In contrast, pigs treated with antibiotic after inoculation (EXP/ABT group) neither showed signs of disease nor seroconverted (IgG) after low dose inoculation. EXP/ABT pigs as well as naïve control pigs [enrofloxacin only (ABT) and challenge only (CHA)] were susceptible to challenge. Variable levels of antibodies in bronchioalveolar fluid and IFN-γ in peripheral blood mononuclear cells were observed after H. parasuis inoculation, but were not associated with protection. In summary, only pigs treated before low dose H. parasuis inoculation seroconverted and were protected against subsequent challenge. Results from this study can help determine timing of antimicrobial use and contribute to our current understanding of judicious antibiotic use.</description><subject>Animals</subject><subject>Anti-Bacterial Agents - administration & dosage</subject><subject>Antibiotics</subject><subject>Antibodies, Bacterial - blood</subject><subject>Antimicrobial agents</subject><subject>Bacterial infections</subject><subject>Colonization</subject><subject>Enrofloxacin</subject><subject>Female</subject><subject>Fluoroquinolones - administration & dosage</subject><subject>Glasser's disease</subject><subject>Group dynamics</subject><subject>Haemophilus</subject><subject>Haemophilus Infections - drug therapy</subject><subject>Haemophilus Infections - immunology</subject><subject>Haemophilus Infections - veterinary</subject><subject>Haemophilus parasuis</subject><subject>Haemophilus parasuis - immunology</subject><subject>Homology</subject><subject>Immune response</subject><subject>Immunity</subject><subject>Immunity (Disease)</subject><subject>Immunoglobulin G</subject><subject>Inoculation</subject><subject>Interferon</subject><subject>Interferon-gamma - blood</subject><subject>Leukocytes (mononuclear)</subject><subject>Male</subject><subject>Peripheral blood mononuclear cells</subject><subject>Polyserositis</subject><subject>Random Allocation</subject><subject>Respiratory tract</subject><subject>Swine</subject><subject>Swine Diseases - drug therapy</subject><subject>Swine Diseases - immunology</subject><subject>Time Factors</subject><issn>0378-1135</issn><issn>1873-2542</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2017</creationdate><recordtype>article</recordtype><recordid>eNp9kE1r3DAQhkVJaTZp_0Epglx6qF2NPmz5UghhmwQCvTRnocgjqsWWXGkdkn9fLZv20ENOw8DzzsdDyEdgLTDovu7aR9zPwbW8di3wlgn-hmxA96LhSvITsmGi1w2AUKfkrJQdY0wOHXtHTrkGYP3AN-R-6z26PU2eYszJT-nJuhBpivTG4pyWX2FaC11stmUNhYZ4wEOKX-gYCtqC1MaRhnleI9KMZUmx4Hvy1tup4IeXek7uv29_Xt00dz-ub68u7xqnGN83vQAhJB-8G5hFZkcuuR5G5ZTv5SA7L5zWWnnFerQoeQ-eaXQP2iPWT6w4J5-Pc5ecfq9Y9mYOxeE02YhpLQZ0B2qQErqKXvyH7tKaY73OwNDVQ1QHulLySLmcSsnozZLDbPOzAWYO2s3OHLWbg3YD3FTtNfbpZfj6MOP4L_TXcwW-HQGsNh4DZlNcwOhwDLn6NGMKr2_4A63LlQg</recordid><startdate>201702</startdate><enddate>201702</enddate><creator>Macedo, Nubia</creator><creator>Cheeran, Maxim C.J.</creator><creator>Rovira, Albert</creator><creator>Holtcamp, Andrew</creator><creator>Torremorell, Montserrat</creator><general>Elsevier B.V</general><general>Elsevier BV</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7U9</scope><scope>H94</scope><scope>M7N</scope><scope>7X8</scope></search><sort><creationdate>201702</creationdate><title>Effect of enrofloxacin on Haemophilus parasuis infection, disease and immune response</title><author>Macedo, Nubia ; Cheeran, Maxim C.J. ; Rovira, Albert ; Holtcamp, Andrew ; Torremorell, Montserrat</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c502t-73133429fc90ae0ad24289d5c5f74946f3c8885f507eae4271f08ecb8fee496a3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2017</creationdate><topic>Animals</topic><topic>Anti-Bacterial Agents - administration & dosage</topic><topic>Antibiotics</topic><topic>Antibodies, Bacterial - blood</topic><topic>Antimicrobial agents</topic><topic>Bacterial infections</topic><topic>Colonization</topic><topic>Enrofloxacin</topic><topic>Female</topic><topic>Fluoroquinolones - administration & dosage</topic><topic>Glasser's disease</topic><topic>Group dynamics</topic><topic>Haemophilus</topic><topic>Haemophilus Infections - drug therapy</topic><topic>Haemophilus Infections - immunology</topic><topic>Haemophilus Infections - veterinary</topic><topic>Haemophilus parasuis</topic><topic>Haemophilus parasuis - immunology</topic><topic>Homology</topic><topic>Immune response</topic><topic>Immunity</topic><topic>Immunity (Disease)</topic><topic>Immunoglobulin G</topic><topic>Inoculation</topic><topic>Interferon</topic><topic>Interferon-gamma - blood</topic><topic>Leukocytes (mononuclear)</topic><topic>Male</topic><topic>Peripheral blood mononuclear cells</topic><topic>Polyserositis</topic><topic>Random Allocation</topic><topic>Respiratory tract</topic><topic>Swine</topic><topic>Swine Diseases - drug therapy</topic><topic>Swine Diseases - immunology</topic><topic>Time Factors</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Macedo, Nubia</creatorcontrib><creatorcontrib>Cheeran, Maxim C.J.</creatorcontrib><creatorcontrib>Rovira, Albert</creatorcontrib><creatorcontrib>Holtcamp, Andrew</creatorcontrib><creatorcontrib>Torremorell, Montserrat</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Virology and AIDS Abstracts</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>Algology Mycology and Protozoology Abstracts (Microbiology C)</collection><collection>MEDLINE - Academic</collection><jtitle>Veterinary microbiology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Macedo, Nubia</au><au>Cheeran, Maxim C.J.</au><au>Rovira, Albert</au><au>Holtcamp, Andrew</au><au>Torremorell, Montserrat</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Effect of enrofloxacin on Haemophilus parasuis infection, disease and immune response</atitle><jtitle>Veterinary microbiology</jtitle><addtitle>Vet Microbiol</addtitle><date>2017-02</date><risdate>2017</risdate><volume>199</volume><spage>91</spage><epage>99</epage><pages>91-99</pages><issn>0378-1135</issn><eissn>1873-2542</eissn><abstract>•Enrofloxacin treatment before low dose H. parasuis inoculation did not interfere with H. parasuis infection, subsequent seroconversion, and protection against challenge.•Pigs treated with enrofloxacin after low dose H. parasuis inoculation did not seroconvert and were susceptible to subsequent challenge.•Results from this study can help determine timing of antimicrobial use and contribute to our current understanding of judicious antibiotic use.
Haemophilus parasuis, the causative agent of Glasser’s disease, is a pathogen that colonizes the upper respiratory tract (URT) of pigs, invades the bloodstream and causes polyserositis. Because antimicrobials are highly effective against H. parasuis, we hypothesized that they could have a detrimental effect on the establishment of an immune response if given at the time of URT colonization. In this study, we characterized clinical outcomes and antibody and IFN-γ responses to H. parasuis in pigs treated with enrofloxacin before or after low dose inoculation with a pathogenic H. parasuis strain. Pigs that were only inoculated with the agent (EXP group) and pigs that were treated with enrofloxacin and then inoculated (ABT/EXP group) developed signs of disease starting at 4days post inoculation (DPI), presented a significant increase in serum IgG and were protected against a subsequent homologous challenge. In contrast, pigs treated with antibiotic after inoculation (EXP/ABT group) neither showed signs of disease nor seroconverted (IgG) after low dose inoculation. EXP/ABT pigs as well as naïve control pigs [enrofloxacin only (ABT) and challenge only (CHA)] were susceptible to challenge. Variable levels of antibodies in bronchioalveolar fluid and IFN-γ in peripheral blood mononuclear cells were observed after H. parasuis inoculation, but were not associated with protection. In summary, only pigs treated before low dose H. parasuis inoculation seroconverted and were protected against subsequent challenge. Results from this study can help determine timing of antimicrobial use and contribute to our current understanding of judicious antibiotic use.</abstract><cop>Netherlands</cop><pub>Elsevier B.V</pub><pmid>28110792</pmid><doi>10.1016/j.vetmic.2016.12.032</doi><tpages>9</tpages><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0378-1135 |
ispartof | Veterinary microbiology, 2017-02, Vol.199, p.91-99 |
issn | 0378-1135 1873-2542 |
language | eng |
recordid | cdi_proquest_miscellaneous_1861594416 |
source | ScienceDirect Journals |
subjects | Animals Anti-Bacterial Agents - administration & dosage Antibiotics Antibodies, Bacterial - blood Antimicrobial agents Bacterial infections Colonization Enrofloxacin Female Fluoroquinolones - administration & dosage Glasser's disease Group dynamics Haemophilus Haemophilus Infections - drug therapy Haemophilus Infections - immunology Haemophilus Infections - veterinary Haemophilus parasuis Haemophilus parasuis - immunology Homology Immune response Immunity Immunity (Disease) Immunoglobulin G Inoculation Interferon Interferon-gamma - blood Leukocytes (mononuclear) Male Peripheral blood mononuclear cells Polyserositis Random Allocation Respiratory tract Swine Swine Diseases - drug therapy Swine Diseases - immunology Time Factors |
title | Effect of enrofloxacin on Haemophilus parasuis infection, disease and immune response |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-20T17%3A24%3A21IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Effect%20of%20enrofloxacin%20on%20Haemophilus%20parasuis%20infection,%20disease%20and%20immune%20response&rft.jtitle=Veterinary%20microbiology&rft.au=Macedo,%20Nubia&rft.date=2017-02&rft.volume=199&rft.spage=91&rft.epage=99&rft.pages=91-99&rft.issn=0378-1135&rft.eissn=1873-2542&rft_id=info:doi/10.1016/j.vetmic.2016.12.032&rft_dat=%3Cproquest_cross%3E1963135618%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c502t-73133429fc90ae0ad24289d5c5f74946f3c8885f507eae4271f08ecb8fee496a3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=1963135618&rft_id=info:pmid/28110792&rfr_iscdi=true |